Market Closed -
Toronto S.E.
03:46:01 2024-05-03 pm EDT
|
5-day change
|
1st Jan Change
|
0.055
CAD
|
0.00%
|
|
0.00%
|
-15.38%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
17.8
|
135.3
|
159.2
|
61.62
|
18.14
|
16.21
|
Enterprise Value (EV)
1 |
17.8
|
163.1
|
194.9
|
61.62
|
18.14
|
16.21
|
P/E ratio
|
-
|
-15
x
|
-12.2
x
|
-5.1
x
|
-1.08
x
|
-1.38
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.76
x
|
8.1
x
|
2.6
x
|
0.61
x
|
0.24
x
|
0.2
x
|
EV / Revenue
|
1.76
x
|
8.1
x
|
2.6
x
|
0.61
x
|
0.24
x
|
0.2
x
|
EV / EBITDA
|
-10.8
x
|
-87.1
x
|
-2,342
x
|
20.8
x
|
12.2
x
|
5.06
x
|
EV / FCF
|
-5,320,952
x
|
-18,277,922
x
|
-8,883,213
x
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
104,698
|
150,340
|
218,125
|
241,651
|
279,040
|
294,707
|
Reference price
2 |
0.1700
|
0.9000
|
0.7300
|
0.2550
|
0.0650
|
0.0550
|
Announcement Date
|
4/28/20
|
4/30/21
|
5/2/22
|
4/26/23
|
4/30/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
10.1
|
16.71
|
61.13
|
101
|
76.58
|
81.41
|
EBITDA
1 |
-1.644
|
-1.553
|
-0.068
|
2.959
|
1.49
|
3.206
|
EBIT
|
-
|
-2.299
|
-4.319
|
-6.248
|
-
|
-
|
Operating Margin
|
-
|
-13.75%
|
-7.07%
|
-6.19%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-7.267
|
-12.82
|
-11.8
|
-18.17
|
-9.291
|
Net income
1 |
-
|
-7.187
|
-12.7
|
-11.58
|
-15.48
|
-9.291
|
Net margin
|
-
|
-43%
|
-20.77%
|
-11.47%
|
-20.21%
|
-11.41%
|
EPS
2 |
-
|
-0.0600
|
-0.0600
|
-0.0500
|
-0.0600
|
-0.0400
|
Free Cash Flow
|
-3.345
|
-7.403
|
-17.92
|
-
|
-
|
-
|
FCF margin
|
-33.12%
|
-44.29%
|
-29.32%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/28/20
|
4/30/21
|
5/2/22
|
4/26/23
|
4/30/24
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
18
|
22.9
|
25.94
|
25.55
|
26.18
|
23.31
|
20.32
|
18.28
|
19.4
|
18.59
|
EBITDA
1 |
-0.587
|
0.54
|
1.157
|
0.6
|
0.792
|
0.005
|
0.673
|
0.047
|
0.703
|
0.067
|
EBIT
|
-1.963
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-10.9%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-1.646
|
-3.066
|
-2.12
|
-4.966
|
-2.646
|
-3.707
|
-3.32
|
-8.451
|
Net income
1 |
-2.923
|
-
|
-1.592
|
-3.012
|
-2.066
|
-4.912
|
-2.521
|
-3.582
|
-3.24
|
-6.138
|
Net margin
|
-16.23%
|
-
|
-6.14%
|
-11.79%
|
-7.89%
|
-21.08%
|
-12.41%
|
-19.59%
|
-16.7%
|
-33.02%
|
EPS
2 |
-0.0200
|
-0.0300
|
-0.0100
|
-0.0100
|
-0.0100
|
-0.0200
|
-0.0100
|
-0.0200
|
-0.0100
|
-0.0200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/29/21
|
5/2/22
|
5/30/22
|
8/29/22
|
11/22/22
|
4/26/23
|
5/23/23
|
8/28/23
|
11/27/23
|
4/30/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
27.8
|
35.7
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-17.9
x
|
-525
x
|
-
|
-
|
-
|
Free Cash Flow
|
-3.35
|
-7.4
|
-17.9
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-79.4%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-0.0300
|
-
|
-
|
-
|
Capex
|
0.29
|
0.73
|
4.26
|
-
|
-
|
-
|
Capex / Sales
|
2.85%
|
4.35%
|
6.98%
|
-
|
-
|
-
|
Announcement Date
|
4/28/20
|
4/30/21
|
5/2/22
|
4/26/23
|
4/30/24
|
-
|
Last Close Price
0.055
CAD Average target price
0.2
CAD Spread / Average Target +263.64% Consensus |
1st Jan change
|
Capi.
|
---|
| -15.38% | 11.85M | | +2.56% | 102B | | -1.92% | 66.01B | | +47.62% | 41.76B | | +15.99% | 38.66B | | +4.25% | 32.28B | | +8.78% | 19.57B | | +12.32% | 16.77B | | +17.69% | 15.08B | | +8.31% | 14.83B |
Other Commodity Chemicals
|